CAS 2003197-53-1

I-BET469

CAS : 2003197-53-1

I-BET469 is a peptidomimetic that is being developed for the treatment of cancer. It was designed to bind to the bromodomain, which is an important drug target. I-BET469 has shown anticancer efficacy in preclinical studies in a range of cell lines and animal models. However, this drug also has a number of side effects, including liver toxicity and inflammation.

Formule : C₂₃H₃₀N₄O₄

Degré de pureté : Min. 95%

Masse moléculaire : 426.5 g/mol

Ref: 3D-DFD19753

I-BET469

CAS : 2003197-53-1

I-BET469 is a Bromodomain and Extraterminal Inhibitor with a Low Predicted Human Dose.

Formule : C₂₃H₃₀N₄O₄

Couleur et forme : Solid

Masse moléculaire : 426.51

Ref: TM-T70003